WuXi Biologics

WXXWY

11.7201.74% ( +0.200 )

Delay Trading: Oct 23, 09:55:48 (EDT)

Current ValuationThe current P/E ratio is 32.81, within the reasonable range, cheaper than 61.78% of the time in the past 5 years, and the industry ranks 4/58, the industry Median -2.25.

32.81xP/E

Stock price$11.52Earnings per share$0.35

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific	35.37x	10.53%	$250.15B
DHRUSDanaher	37.29x	20.93%	$161.51B
AUSAgilent Tech	34.04x	12.30%	$49.02B
IQVUSIQVIA	33.32x	0.11%	$45.81B
MTDUSMettler Toledo	37.27x	10.40%	$33.75B
WXXWYUSWuXi Biologics	32.81x	--	$23.64B
MEDPUSMedpace	35.25x	18.50%	$18.25B
QGENUSQiagen NV	25.34x	0.52%	$10.37B
STVNUSStevanato Group SpA	34.14x	8.49%	$5.33B
SHCUSSotera Health	31.65x	154.32%	$5.17B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.